The government’s race to secure vaccine deals makes a mockery of its own rhetoric on equitable global access, say public health and social justice organisations.
Lower-income countries across the world will now be able to access life-saving vaccines which protect against the leading cause of pneumonia, for US$ 2 per dose.
The availability of an effective vaccine and treatments do not negate the importance of building trust and understanding in communities affected by the Ebola outbreak, warns the International Federation of Red Cross and Red Crescent Societies.